Stemline Therapeutics GmbH
–
United States
... Nexpovio’s marketing authorization is valid in the EU Member States as well as Iceland, Liechtenstein, Norway, and Northern Ireland, and it has been commercially available in Germany and Austria since the fourth quarter of 2022. In January 2023, ... - Apr 18